ERCC1, XRCC1, and GSTP1 Polymorphisms and Treatment Outcomes of Advanced Epithelial Ovarian Cancer Patients Treated with Platinum-based Chemotherapy

OBJECTIVE: The first line regimen for treating epithelial ovarian cancer (EOC) is platinum-based chemotherapy. Various factors impact its effectiveness including polymorphisms of enzymes in platinum-related metabolism processes. METHODS: We conducted the study to investigate the association between...

Descripción completa

Detalles Bibliográficos
Autores principales: Liblab, Salisa, Vasuratana, Apichai, Areepium, Nutthada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573419/
https://www.ncbi.nlm.nih.gov/pubmed/32711417
http://dx.doi.org/10.31557/APJCP.2020.21.7.1925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573419/
https://www.ncbi.nlm.nih.gov/pubmed/32711417
http://dx.doi.org/10.31557/APJCP.2020.21.7.1925

Ejemplares similares